Delivery Order SPE2DB22D1106-SPE2DB25FDTH9

Award Date 1/6/25
Potential Completion Date 1/7/25
Potential Value $2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,950.68, is for the delivery of Wegovy 1.7 mg/0.75 ml pens. This is a firm fixed-price delivery order contract with a completion date of February 7, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Wegovy 0.25 mg/0.5 ml pens, with a ceiling value of $3,303.84 and a completion date of December 30, 2024. This is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,436.25, is for the delivery of Wegovy 1 mg/0.5 ml pens. It is a firm fixed-price delivery order contract with a completion date of February 7, 2025. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, with a ceiling value of $1,228.50, is for the delivery of Wegovy 2.4 mg/0.75 ml pen 0.75 ml, a prescription medication. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,374.92 firm-fixed-price delivery order is for the supply of Wegovy 1.7 mg/0.75 ml pens with a completion date of September 19, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Wegovy 1 mg/0.5 ml pens. The contract has a ceiling value of $2,016.90 and a completion date of May 5, 2023. It is a firm fixed-price delivery order contract, without any set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical, which serves as a...
This federal contract award to AmerisourceBergen Drug Corp. is a delivery order valued at $1,958.48 for the supply of the pharmaceutical product Wegovy, a 0.25 mg/0.5 ml pen. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of December 12, 2024. The contract is a firm fixed-price arrangement. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Wegovy 0.25 mg/0.5 ml pens, a specialty medication. The award has a ceiling value of $11,558.21 and an ultimate completion date of January 29, 2025. This is a delivery order contract with a firm fixed price pricing type. AmerisourceBergen Drug Corp is the prime contractor, and there is no...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of 0.5 mg/0.5 ml Wegovy pens. The contract has a ceiling value of $36,074.22 and a completion date of January 27, 2025. It is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Wegovy 2.4 mg/0.75 ml pens. The contract is a firm fixed-price contract with a ceiling value of $2,399.82 and a period of performance through September 10, 2024. AmerisourceBergen, as a major pharmaceutical distributor, leverages its extensive supply chain to provide a wide range of essential medical commodities to various federal agencies and healthcare programs. This...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB25FDTH9
    Delivery Order

This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of Wegovy 2.4 mg/0.75 ml pens, with a ceiling value of $2,047.50 and a completion date of January 7, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific award does not have a set-aside designation, indicating open competition.

Generated 4/13/25, 12:52 AM